Sylwia Rzońca

1.1k citations
12 papers · 781 indexed · h-index 7
Topics
Bone and Joint Diseases (3 papers)Peroxisome Proliferator-Activated Receptors (3 papers)RNA modifications and cancer (2 papers)

In The Last Decade

Sylwia Rzońca

12 papers receiving 759 citations

Peers

Sylwia Rzońca
Comparison fields: 5 of 72
  • Molecular Biology 577
  • Orthopedics and Sports Medicine 269
  • Oncology 234
  • Physiology 128
  • Endocrinology, Diabetes and Metabolism 112
Replace Jeshmi Jeyabalan with:
Jeshmi Jeyabalan United Kingdom
Julie L. Frey United States
Akihiko Karibe Japan
Azeb Haile United States
Yasuo Totsuka Japan
Wilfried Seifert Germany
Takehiko Murakami Japan
Kenjiro Yamakawa Japan
Pan Tan China
Sylwia Rzońca relative to Jeshmi Jeyabalan United Kingdom Jeshmi Jeyabalan's profile →
Citations per field
00.5×3.1×
Jeshmi Jeyabalan · 1×
Citations per year

Countries citing papers authored by Sylwia Rzońca

Since Specialization
Citations

This map shows the geographic impact of Sylwia Rzońca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylwia Rzońca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylwia Rzońca more than expected).

Fields of papers citing papers by Sylwia Rzońca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylwia Rzońca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylwia Rzońca. The network helps show where Sylwia Rzońca may publish in the future.

Co-authorship network of co-authors of Sylwia Rzońca

This figure shows the co-authorship network connecting the top 25 collaborators of Sylwia Rzońca. A scholar is included among the top collaborators of Sylwia Rzońca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylwia Rzońca. Sylwia Rzońca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 6
2 20
3 2
4 5
5 2
6 6
7 2
8 15
9
Proapoptotic gene therapy and chemosensitivity of cancer cells
1
10 240
11 111
12 371

About Sylwia Rzońca

Sylwia Rzońca is a scholar working on Developmental Biology, Orthopedics and Sports Medicine and Genetics, having authored 12 papers that have together received 781 indexed citations. Recurring topics across this work include Bone and Joint Diseases (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (269 citations), Oncology (234 citations) and Molecular Biology (577 citations). Sylwia Rzońca has collaborated with scholars based in Poland, United States and United Kingdom. Frequent co-authors include Beata Lecka‐Czernik, Larry J. Suva, Dana Gaddy, Donna Montague, Oxana P. Lazarenko, William R. Hogue, Frances L. Swain, Maciej Małecki, Marta Zalewska and Monika Goś. Their work appears in journals such as Endocrinology, Bone and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026